首页> 外文期刊>Korean Circulation Journal >Determination of Safe Contrast Media Dosage to Estimated Glomerular Filtration Rate Ratios to Avoid Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention
【24h】

Determination of Safe Contrast Media Dosage to Estimated Glomerular Filtration Rate Ratios to Avoid Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention

机译:确定安全造影剂剂量与估计的肾小球滤过率比率,以避免选择性经皮冠状动脉介入治疗后造影剂诱发的肾病

获取原文
           

摘要

Background and Objectives To avoid the risk of developing contrast-induced nephropathy (CIN), it has been suggested that patients be subjected to a minimal necessary dose of contrast medium (CM-dose). However, often it is not easy to determine such a dose. This study assessed the usefulness of the ratio of CM-dose to estimated glomerular filtration rate (eGFR) in predicting the risks of CIN and sought to determine the safe level of CM-dose/eGFR in patients undergoing non-emergent percutaneous coronary intervention (PCI). Subjects and Methods We enrolled a total of 226 patients and calculated the ratio of CM-dose using grams of iodine (g-I) to eGFR, thus expressing it as g-I/eGFR. Among the CIN patients, those with ne-phropathy requiring dialysis (NRD) were also evaluated. Results Overall, there were 16 cases (7.1%) of CIN. On univariate and multivariate regression analysis, g-I/eGFR alone was found to be an independent predictor for CIN (hazard ratio=10.73, p Conclusion It can be concluded that a g-I/eGFR
机译:背景和目的为了避免发展为对比剂诱发的肾病(CIN)的风险,已建议患者应接受最低限度必需剂量的对比剂(CM剂量)。但是,通常很难确定这种剂量。这项研究评估了CM剂量与估计的肾小球滤过率(eGFR)之比在预测CIN风险中的有效性,并试图确定接受非紧急经皮冠状动脉介入治疗(PCI)的患者CM剂量/ eGFR的安全水平)。受试者和方法我们共纳入226名患者,并使用碘(g-I)与eGFR的克数计算CM剂量比,从而将其表示为g-I / eGFR。在CIN患者中,还评估了需要透析(NRD)的肾病患者。结果总体上,有16例CIN病例(7.1%)。通过单因素和多因素回归分析,仅发现g-I / eGFR是CIN的独立预测因子(危险比= 10.73,p结论)可以得出结论,认为g-I / eGFR

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号